Vimarsana
Biggest News Aggregation in the World

Pharmaceutical Ingredient News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharmaceutical Ingredient. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharmaceutical Ingredient Today - Breaking & Trending Today

Penicillin Intermediates Market Size to Grow USD 14330 Million by 2029 at a CAGR of 5.2% - Vimarsana News

Penicillin Intermediates Market Size to Grow USD 14330 Million by 2029 at a CAGR of 5.2%

/PRNewswire/ -- Penicillin Intermediates Market is Segmented by Type (6-APA, Penicillin G Potassium Salt), by Application (Amoxicillin, Ampicillin Sodium)...

Active Pharmaceutical Ingredient CDMO Market Analysis Report 2024-2030: Patient Expiration, Expanding Consumption of Biopharmaceuticals, Demand for Generic Drugs Driving Expansion - Vimarsana News

Active Pharmaceutical Ingredient CDMO Market Analysis Report 2024-2030: Patient Expiration, Expanding Consumption of Biopharmaceuticals, Demand for Generic Drugs Driving Expansion

/PRNewswire/ -- The "Active Pharmaceutical Ingredient CDMO Market Size, Share & Trends Analysis Report By Product, By Synthesis, By Drug, By Application, By...

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2023 - Vimarsana News

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2023

RANCHO CUCAMONGA - Amphastar Pharmaceuticals, Inc. today reported results for the three months and full-year ended December 31, 2023. Fourth Quarter Highlights Net revenues of $178.1 million for...

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended Decembe - Vimarsana News

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended Decembe

Reports Net Revenues of $178.1 Million for the Three Months Ended December 31, 2023RANCHO CUCAMONGA, CA / ACCESSWIRE / February 28, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") today reported results for the three months and full-year ended December 31, 2023...

Oncology Dominates Active Pharmaceutical Ingredient CDMO Market with 35.5% Revenue Share in 2022, Fueled by Growing Demand for Potent APIs - Vimarsana News

Oncology Dominates Active Pharmaceutical Ingredient CDMO Market with 35.5% Revenue Share in 2022, Fueled by Growing Demand for Potent APIs

/PRNewswire/ -- The "Active Pharmaceutical Ingredient CDMO Market Size, Share & Trends Analysis Report By Product (Highly Potent API, Antibody Drug Conjugate),...